LDHA and urinary bladder cancer: Indeed, LDHA overexpression has been documented across various malignancies, including breast, colorectal, gastric, lung, liver, brain, and bladder cancers, positioning LDHA as an important therapeutic target and prognostic biomarker [8,9].